LADA and T1D in Estonian population - Two different genetic risk profiles

Gene

Volumn 497, Issue 2, 2012, Pages 285-291

  Kisand, Kalle ^a   Uibo, Raivo ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Diabetes; Genetic; LADA; T1D; T2D

Indexed keywords

ANTIGEN; AUTOANTIBODY; CD226 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DQB1 ANTIGEN; INSULIN; INTERLEUKIN 2 RECEPTOR ALPHA; NAA25 ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ESTONIA; FEMALE; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES IN ADULT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ACETYLTRANSFERASES; ADULT; AGE OF ONSET; ALLELES; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ESTONIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; EVOLUTION, MOLECULAR; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HAPLOTYPES; HLA-DQ BETA-CHAINS; HOMEODOMAIN PROTEINS; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INSULIN; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84858279947     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.01.089     Document Type: Article

References (42)

1. American diabetes association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl 1):S62-S69.
2. Andersen M.K., et al. Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care 2010, 33(9):2062-2064.
3. Bain S.C., et al. Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nat. Genet. 1992, 2(3):212-215.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
5. Bennett S.T., et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 1995, 9(3):284-292.
6. Bjornvold M., et al. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 2008, 51(4):589-596.
7. Bottini N., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 2004, 36(4):337-338.
8. Caputo M., et al. Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA). Autoimmunity 2005, 38(4):277-281.
9. Caputo M., Cerrone G.E., Mazza C., Cedola N., Targovnik H.M., Gustavo D.F. No evidence of association of CTLA-4-318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes. Immunol. Invest. 2007, 36(3):259-270.
10. Cervin C., et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008, 57(5):1433-1437.
11. Desai M., et al. An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia 2007, 50(1):68-73.
12. Douroudis K., et al. Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population. Tissue Antigens 2008, 72(5):425-430.
13. Douroudis K., et al. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum. Immunol. 2009, 70(7):536-539.
14. Douroudis K., Nemvalts V., Rajasalu T., Kisand K., Uibo R. The CD226 gene in susceptibility of type 1 diabetes. Tissue Antigens 2009, 74(5):417-419.
15. Douroudis K., Prans E., Kisand K., Nemvalts V., Uibo R. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms are associated with latent autoimmune diabetes in adults. Clin. Chim. Acta 2009, 403(1-2):226-228.
16. Douroudis K., Prans E., Uibo R. CTLA-4 promoter polymorphisms are associated with latent autoimmune diabetes in adults. Hum. Immunol. 2009, 70(11):921-924.
17. Douroudis K., Kisand K., Nemvalts V., Rajasalu T., Uibo R. Allelic variants in the PHTF1-PTPN22, C12orf30 and CD226 regions as candidate susceptibility factors for the type 1 diabetes in the Estonian population. BMC Med. Genet. 2010, 11:11.
18. Gillespie K.M., et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004, 364(9446):1699-1700.
19. Graham J., et al. Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. Eur. J. Immunogenet. 1999, 26(2-3):117-127.
20. Grant S.F., Hakonarson H., Schwartz S. Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults?. Endocr. Rev. 2010, 31(2):183-193.
21. Haller K., Kisand K., Nemvalts V., Laine A.P., Ilonen J., Uibo R. Type 1 diabetes is insulin -2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur. J. Clin. Invest. 2004, 34(8):543-548.
22. Haller K., et al. Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens 2007, 69(2):121-127.
23. Hermann R., et al. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes - indication of an increased environmental pressure?. Diabetologia 2003, 46(3):420-425.
24. Hosszufalusi N., et al. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 2003, 26(2):452-457.
25. Ilonen J., Hermann R. Novel gene associations in type 1 diabetes. Curr. Diab. Rep. 2010, 10(5):338-344.
26. Janssens A.C., Pardo M.C., Steyerberg E.W., van Duijn C.M. Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am. J. Hum. Genet. 2004, 74(3):585-588. author reply 588-9.
27. Julier C., et al. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 1991, 354(6349):155-159.
28. Kobayashi T., et al. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults. Ann. N. Y. Acad. Sci. 2006, 1079:60-66.
29. Kukko M., et al. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study. Diabetologia 2003, 46(1):65-70.
30. Metcalfe K.A., Hitman G.A., Fennessy M.J., McCarthy M.I., Tuomilehto J., Tuomilehto-Wolf E. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group. Diabetologia 1995, 38(10):1223-1229.
31. Motzo C., et al. Heterogeneity in the magnitude of the insulin gene effect on HLA risk in type 1 diabetes. Diabetes 2004, 53(12):3286-3291.
32. Rajasalu T., et al. Insulin VNTR I/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes. Diabetes Metab. Res. Rev. 2007, 23(7):567-571.
33. Schernthaner G., Hink S., Kopp H.P., Muzyka B., Streit G., Kroiss A. Progress in the characterization of slowly progressive autoimmune diabetes in adult patients (LADA or type 1.5 diabetes). Exp. Clin. Endocrinol. Diabetes 2001, 109(Suppl 2):S94-S108.
34. Sjoroos M., Iitia A., Ilonen J., Reijonen H., Lovgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 1995, 18(5):870-877.
35. Stenstrom G., Berger B., Borg H., Fernlund P., Dorman J.S., Sundkvist G. HLA-DQ genotypes in classic type 1 diabetes and in latent autoimmune diabetes of the adult. Am. J. Epidemiol. 2002, 156(9):787-796.
36. Todd J.A., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 2007, 39(7):857-864.
37. Tuomi T., et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999, 48(1):150-157.
38. Ueda H., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423(6939):506-511.
39. van der Auwera B.J., Heimberg H., Schrevens A.F., van Waeyenberge C., Flament J., Schuit F.C. 5' insulin gene polymorphism confers risk to IDDM independently of HLA class II susceptibility. Diabetes 1993, 42(6):851-854.
40. Vatay A., et al. Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. Immunol. Lett. 2002, 84(2):109-115.
41. Vella A., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 2005, 76(5):773-779.
42. Zimmet P.Z., et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet. Med. 1994, 11(3):299-303.